Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 4Lymphoid 3Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Lymphoma 160Leukemia 109Burkitt Lymphoma 92Lymphoma, Non-Hodgkin 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Mantle-Cell 70Leukemia, Myeloid, Acute 53Lymphoma, Follicular 49Hodgkin Disease 44Lymphoma, Large-Cell, Immunoblastic 37Leukemia, Lymphocytic, Chronic, B-Cell 33Recurrence 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia, Biphenotypic, Acute 25Lymphoma, B-Cell, Marginal Zone 24Myelodysplastic Syndromes 23Blast Crisis 19Lymphoma, Large-Cell, Anaplastic 18Lymphoma, B-Cell 18Dendritic Cell Sarcoma, Interdigitating 17Congenital Abnormalities 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelomonocytic, Chronic 15Multiple Myeloma 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, T-Cell 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Neoplasms, Plasma Cell 9

Interventions

Temozolomide 9Filgrastim 7Specimen Handling 6X-Rays 5Rituximab 5Radiotherapy 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Psychiatric Rehabilitation 4Nuclear Medicine Department, Hospital 4Methotrexate 4Etoposide 4Cyclophosphamide 4Biopsy 4etoposide phosphate 3Pemetrexed 3Melphalan 3Cytarabine 3Carboplatin 3tazemetostat 2sargramostim 2olaparib 2larotrectinib 2erdafitinib 2ensartinib 2Vincristine 2Vemurafenib 2Topotecan 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Cytarabine × Lymphoid × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00416819 2015-08-20

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

University of California, San Francisco

Phase NA Completed
10 enrolled
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡